The speakers talk about the EY report Pharma supply chains of the future and discuss the impact of global events and how a new supply chain model can emerge. Until recently, the pharma industry has been on the straight path to globalization with integrated supply chains that crossed national borders. A series of geopolitical upheavals though, from the COVID-19 pandemic, to the crisis in Ukraine, caused the industry to re-examine its priorities. The COVID-19 pandemic and global political tensions highlighted the downsides of a highly integrated supply chain with global dependenci ..read more

In this episode, Barend van Bergen, EY Global Long-term Value Methodology Leader and Sonja Haut, Head of Impact Valuation for Novartis discuss how companies are measuring their ESG impact ..read more

In this episode of the EY Health Sciences and Wellness Experience podcast, Pamela Spence, EY Global Health Sciences and Wellness Leader, talks with Nancy Flores, Executive Vice President & Chief Information and Technology Officer for McKesson Corporation, about the unique complexities of healthcare – a sector with new entrants, new regulations, consolidation, pricing pressures, and an ageing population that needs ever more healthcare. But alongside the complexities, there are opportunities to disrupt ..read more

In this episode of the EY Health Sciences and Wellness Experience podcast, Pamela Spence, EY Global Health Sciences and Wellness Leader, speaks with Trecilla Lobo, SVP, People, BenevolentAI, Rabia Khan, Founder/CEO, Ladder Therapeutics, and Samin Saeed, UK Chief Scientific Officer and Medical Director, Novartis, as they discuss their own unique career journeys within the health sciences and wellness industry. They also share with us those critical lessons they have learned from their mentors and supporters along the way ..read more

In this episode of the EY Health Sciences and Wellness Experience Podcast, Pamela Spence, EY Global Health Sciences and Wellness Leader, Jackie Hunter, Board Director of Benevolent AI and Ridwaan Jhetam, VP Global Medical for Hematology, BMS, discuss the important of data and how it can help redesign the health experience. In this wide-ranging discussion, the expert panel approach these issues from their different perspectives. Whether you’re a doctor or researcher, a programmer or a CIO, whether you work in the field or you’re just looking in from outside, you’ll find this an insightful and t ..read more

There are 2,600 cell and gene therapy clinical trials taking place this year. In the US alone, this could translate up to 20 new therapy approvals in 2022, which presents a clear opportunity to make more life-saving therapies available to a greater number of individuals. In this podcast, Adlai Goldberg, Global Digital, Social and Commercial Innovation Life Sciences Leader for EY, talks to Tamie Joeckel – ICON’s Cell and Gene Therapy Global Business Lead, as they discuss what makes an increase in the volume of trials and an acceleration of the clinical trial process significant ..read more

In this first episode of our EY Health Sciences and Wellness Experience podcast series, we explore the emerging and much needed age of “Health Experience.” The Health Sciences and Wellness industry has never been as “front and center” in our lives as it has been in this last year. As all of us, worldwide, ride the various waves of the pandemic, our Health Sciences and Wellness industry has taken the lead in giving care to those who have needed it most. We have also seen a monumental collaborative R&D effort – at a scale never witnessed before – which has resulted in the creation and delive ..read more

In this episode, Barend van Bergen, EY Global Long-term Value Methodology Leader and Sonja Haut, Head of Impact Valuation for Novartis discuss how companies are measuring their ESG impact ..read more

In this episode of the EY Health Sciences and Wellness Experience podcast, Pamela Spence, EY Global Health Sciences and Wellness Leader, talks with Nancy Flores, Executive Vice President & Chief Information and Technology Officer for McKesson Corporation, about the unique complexities of healthcare – a sector with new entrants, new regulations, consolidation, pricing pressures, and an ageing population that needs ever more healthcare. But alongside the complexities, there are opportunities to disrupt ..read more

In this episode of the EY Health Sciences and Wellness Experience podcast, Pamela Spence, EY Global Health Sciences and Wellness Leader, speaks with Trecilla Lobo, SVP, People, BenevolentAI, Rabia Kahn, Founder/CEO, Ladder Therapeutics, and Samin Saeed, UK Chief Scientific Officer and Medical Director, Novartis, as they discuss their own unique career journeys within the health sciences and wellness industry. They also share with us those critical lessons they have learned from their mentors and supporters along the way ..read more